2seventy bio to Participate in Upcoming Investor Conferences
May 23 2024 - 7:00AM
Business Wire
2seventy bio, Inc. (Nasdaq: TSVT) announced today that members
of the management team will present at the following upcoming
investor conferences:
- TD Cowen 5th Annual Oncology Innovation Summit: Insights for
ASCO & EHA in a virtual fireside chat on Tuesday, May 28, 2024
at 8:30 a.m. ET
- Goldman Sachs 45th Annual Global Healthcare Conference in Miami
Beach, FL, on Monday, June 10, 2024 at 8:40 a.m. ET
Live webcasts of the fireside chats will be available via the
Investors and Media section of the company’s website at
https://ir.2seventybio.com. Replays will be archived on the
2seventy bio website for 30 days following the events.
About 2seventy bio Our name,
2seventy bio, reflects why we do what we do - TIME. Cancer rips
time away, and our goal is to work at the maximum speed of
translating human thought into action – 270 miles per hour – to
give the people we serve more time. With a deep understanding of
the human body’s immune response to tumor cells and how to
translate cell therapies into practice, we’re applying this
knowledge to deliver the first FDA-approved CAR T cell therapy for
multiple myeloma to as many patients as possible. Importantly, we
remain focused on accomplishing our mission by staying genuine and
authentic to our “why” and keeping our people and culture top of
mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: X (Twitter) and
LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240522999662/en/
Investors: Vicki Eatwell, CFO
vicki.eatwell@2seventybio.com Media: Jenn Snyder
Jenn.snyder@2seventybio.com
2seventy bio (NASDAQ:TSVT)
Historical Stock Chart
From Oct 2024 to Nov 2024
2seventy bio (NASDAQ:TSVT)
Historical Stock Chart
From Nov 2023 to Nov 2024